Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Mycobacterium sarraceniae sp. nov. and Mycobacterium helvum sp. nov., isolated from the pitcher plant Sarracenia purpurea.

Tran PM, Dahl JL.

Int J Syst Evol Microbiol. 2016 Nov;66(11):4480-4485. doi: 10.1099/ijsem.0.001377. Epub 2016 Aug 4.

PMID:
27498537
2.

A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria.

Niki M, Niki M, Tateishi Y, Ozeki Y, Kirikae T, Lewin A, Inoue Y, Matsumoto M, Dahl JL, Ogura H, Kobayashi K, Matsumoto S.

J Biol Chem. 2012 Aug 10;287(33):27743-52. doi: 10.1074/jbc.M111.333385. Epub 2012 May 30.

3.

Mycobacterium minnesotense sp. nov., a photochromogenic bacterium isolated from sphagnum peat bogs.

Hannigan GD, Krivogorsky B, Fordice D, Welch JB, Dahl JL.

Int J Syst Evol Microbiol. 2013 Jan;63(Pt 1):124-8. doi: 10.1099/ijs.0.037291-0. Epub 2012 Feb 17.

PMID:
22345139
4.

Role of phase variation in the resistance of Myxococcus xanthus fruiting bodies to Caenorhabditis elegans predation.

Dahl JL, Ulrich CH, Kroft TL.

J Bacteriol. 2011 Oct;193(19):5081-9. doi: 10.1128/JB.05383-11. Epub 2011 Aug 5.

5.

Small acid-soluble proteins with intrinsic disorder are required for UV resistance in Myxococcus xanthus spores.

Dahl JL, Fordice D.

J Bacteriol. 2011 Jun;193(12):3042-8. doi: 10.1128/JB.00293-11. Epub 2011 Apr 22.

6.

The wag31 gene of Mycobacterium tuberculosis is positively regulated by the stringent response.

Dahl JL, Lau Bonilla D.

FEMS Microbiol Lett. 2011 Jun;319(2):153-9. doi: 10.1111/j.1574-6968.2011.02278.x. Epub 2011 May 6.

7.

Deletion of the histone-like protein (Hlp) from Mycobacterium smegmatis results in increased sensitivity to UV exposure, freezing and isoniazid.

Whiteford DC, Klingelhoets JJ, Bambenek MH, Dahl JL.

Microbiology. 2011 Feb;157(Pt 2):327-35. doi: 10.1099/mic.0.045518-0. Epub 2010 Oct 21.

PMID:
20966096
8.

Removal of opioid/acetaminophen combination prescription pain medications: assessing the evidence for hepatotoxicity and consequences of removal of these medications.

Michna E, Duh MS, Korves C, Dahl JL.

Pain Med. 2010 Mar;11(3):369-78. doi: 10.1111/j.1526-4637.2010.00811.x.

PMID:
20447306
9.

Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.

Wolfert MZ, Gilson AM, Dahl JL, Cleary JF.

Pain Med. 2010 Mar;11(3):425-34. doi: 10.1111/j.1526-4637.2009.00761.x. Epub 2009 Dec 9. Review.

PMID:
20002590
10.

Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatis.

Arora K, Whiteford DC, Lau-Bonilla D, Davitt CM, Dahl JL.

J Bacteriol. 2008 Jun;190(12):4291-300. doi: 10.1128/JB.00023-08. Epub 2008 Apr 11.

11.

Demonstration of allelic exchange in the slow-growing bacterium Mycobacterium avium subsp. paratuberculosis, and generation of mutants with deletions at the pknG, relA, and lsr2 loci.

Park KT, Dahl JL, Bannantine JP, Barletta RG, Ahn J, Allen AJ, Hamilton MJ, Davis WC.

Appl Environ Microbiol. 2008 Mar;74(6):1687-95. doi: 10.1128/AEM.01208-07. Epub 2008 Jan 11.

12.

Identification of major sporulation proteins of Myxococcus xanthus using a proteomic approach.

Dahl JL, Tengra FK, Dutton D, Yan J, Andacht TM, Coyne L, Windell V, Garza AG.

J Bacteriol. 2007 Apr;189(8):3187-97. Epub 2007 Feb 9.

13.

Expression, production and release of the Eis protein by Mycobacterium tuberculosis during infection of macrophages and its effect on cytokine secretion.

Samuel LP, Song CH, Wei J, Roberts EA, Dahl JL, Barry CE 3rd, Jo EK, Friedman RL.

Microbiology. 2007 Feb;153(Pt 2):529-40.

PMID:
17259625
14.

The Discomfort Behavior Scale: a measure of discomfort in the cognitively impaired based on the Minimum Data Set 2.0.

Stevenson KM, Brown RL, Dahl JL, Ward SE, Brown MS.

Res Nurs Health. 2006 Dec;29(6):576-87.

PMID:
17131282
15.

CbgA, a protein involved in cortex formation and stress resistance in Myxococcus xanthus spores.

Tengra FK, Dahl JL, Dutton D, Caberoy NB, Coyne L, Garza AG.

J Bacteriol. 2006 Dec;188(23):8299-302. Epub 2006 Sep 22.

16.

The WPI's review of Wisconsin's managed care climate for pain management: opportunities for improvement.

Pellino TA, Gordon DB, Dahl JL; Wisconsin Pain Initiative.

WMJ. 2006 Jun;105(4):27-31, 50.

17.
18.

How to reduce fears of legal/regulatory scrutiny in managing pain in cancer patients.

Dahl JL.

J Support Oncol. 2005 Sep-Oct;3(5):384-8. No abstract available.

PMID:
16218263
19.

American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force.

Gordon DB, Dahl JL, Miaskowski C, McCarberg B, Todd KH, Paice JA, Lipman AG, Bookbinder M, Sanders SH, Turk DC, Carr DB.

Arch Intern Med. 2005 Jul 25;165(14):1574-80. Review.

PMID:
16043674
20.
21.

Perspectives on increased family reports of pain in dying hospitalized patients.

Dahl JL.

J Palliat Med. 2000 Winter;3(4):399-401. No abstract available.

PMID:
15859690
22.

The relA homolog of Mycobacterium smegmatis affects cell appearance, viability, and gene expression.

Dahl JL, Arora K, Boshoff HI, Whiteford DC, Pacheco SA, Walsh OJ, Lau-Bonilla D, Davis WB, Garza AG.

J Bacteriol. 2005 Apr;187(7):2439-47.

23.

Analysis of the immune response to Mycobacterium avium subsp. paratuberculosis in experimentally infected calves.

Koo HC, Park YH, Hamilton MJ, Barrington GM, Davies CJ, Kim JB, Dahl JL, Waters WR, Davis WC.

Infect Immun. 2004 Dec;72(12):6870-83.

24.

Electron microscopy analysis of Mycobacterium tuberculosis cell division.

Dahl JL.

FEMS Microbiol Lett. 2004 Nov 1;240(1):15-20.

25.

A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.

Gilson AM, Ryan KM, Joranson DE, Dahl JL.

J Pain Symptom Manage. 2004 Aug;28(2):176-88.

PMID:
15276196
26.

Pain: impediments and suggestions for solutions.

Dahl JL.

J Natl Cancer Inst Monogr. 2004;(32):124-6.

PMID:
15263053
27.

Quality improvement challenges in pain management.

Gordon DB, Dahl JL.

Pain. 2004 Jan;107(1-2):1-4. No abstract available.

PMID:
14715381
28.

Institutionalizing pain management: the Post-Operative Pain Management Quality Improvement Project.

Dahl JL, Gordon D, Ward S, Skemp M, Wochos S, Schurr M.

J Pain. 2003 Sep;4(7):361-71.

PMID:
14622678
29.

The myths and realities of pain control with opioids.

Dahl JL.

WMJ. 2003;102(5):19. No abstract available.

30.

The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice.

Dahl JL, Kraus CN, Boshoff HI, Doan B, Foley K, Avarbock D, Kaplan G, Mizrahi V, Rubin H, Barry CE 3rd.

Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10026-31. Epub 2003 Aug 1.

31.

The new JCAHO pain assessment standards: implications for the medical director.

Dahl JL, Saeger L, Stein W, Huss RD.

J Am Med Dir Assoc. 2000 Nov-Dec;1(6 Suppl):S24-31. No abstract available.

PMID:
12818012
32.

Working with regulators to improve the standard of care in pain management: the U.S. experience.

Dahl JL.

J Pain Symptom Manage. 2002 Aug;24(2):136-46. Review. No abstract available.

PMID:
12231131
33.

Success of the state pain initiatives: moving pain management forward.

Dahl JL, Bennett ME, Bromley MD, Joranson DE.

Cancer Pract. 2002 May-Jun;10 Suppl 1:S9-S13.

PMID:
12027963
34.

Pain management and prescription monitoring.

Joranson DE, Carrow GM, Ryan KM, Schaefer L, Gilson AM, Good P, Eadie J, Peine S, Dahl JL.

J Pain Symptom Manage. 2002 Mar;23(3):231-8. Review.

PMID:
11888721
35.

Pain management, controlled substances, and state medical board policy: a decade of change.

Joranson DE, Gilson AM, Dahl JL, Haddox JD.

J Pain Symptom Manage. 2002 Feb;23(2):138-47. Review.

PMID:
11844634
36.

The new JCAHO pain standards: implications for pain management nurses.

Berry PH, Dahl JL.

Pain Manag Nurs. 2000 Mar;1(1):3-12. Review.

PMID:
11706454
37.

Advances in pain management good for patients and physicians.

Dahl JL.

WMJ. 2001;100(5):15-6. No abstract available.

PMID:
11579793
38.

Subcellular localization of the Iitracellular survival-enhancing Eis protein of Mycobacterium tuberculosis.

Dahl JL, Wei J, Moulder JW, Laal S, Friedman RL.

Infect Immun. 2001 Jul;69(7):4295-302.

39.

Trends in medical use and abuse of opioid analgesics.

Joranson DE, Ryan KM, Gilson AM, Dahl JL.

JAMA. 2000 Apr 5;283(13):1710-4.

PMID:
10755497
40.

MSJAMA: improving the practice of pain management.

Dahl JL.

JAMA. 2000 Dec 6;284(21):2785. Review. No abstract available.

PMID:
11105189
41.

Identification of a Mycobacterium tuberculosis gene that enhances mycobacterial survival in macrophages.

Wei J, Dahl JL, Moulder JW, Roberts EA, O'Gaora P, Young DB, Friedman RL.

J Bacteriol. 2000 Jan;182(2):377-84.

42.

Separate contributions of UhpA and CAP to activation of transcription of the uhpT promoter of Escherichia coli.

Olekhnovich IN, Dahl JL, Kadner RJ.

J Mol Biol. 1999 Oct 8;292(5):973-86.

PMID:
10512697
43.

A role model program to promote institutional changes for management of acute and cancer pain.

Weissman DE, Griffie J, Gordon DB, Dahl JL.

J Pain Symptom Manage. 1997 Nov;14(5):274-9.

PMID:
9392920
44.
45.

The controversy of physician-assisted suicide.

Dahl JL.

J Fla Med Assoc. 1996 Dec;83(10):675-6. No abstract available.

PMID:
9019056
46.

Effective pain management in terminal care.

Dahl JL.

Clin Geriatr Med. 1996 May;12(2):279-300. Review.

PMID:
8799348
47.

Teaching cancer pain management: durability of educational effects of a role model program.

Janjan NA, Martin CG, Payne R, Dahl JL, Weissman DE, Hill CS.

Cancer. 1996 Mar 1;77(5):996-1001.

PMID:
8608495
48.

Update on the cancer pain role model education program.

Weissman DE, Dahl JL.

J Pain Symptom Manage. 1995 May;10(4):292-7.

PMID:
7541436
49.

Transcription activation at the Escherichia coli uhpT promoter by the catabolite gene activator protein.

Merkel TJ, Dahl JL, Ebright RH, Kadner RJ.

J Bacteriol. 1995 Apr;177(7):1712-8.

50.

A transmembrane signalling complex controls transcription of the Uhp sugar phosphate transport system.

Kadner RJ, Island MD, Dahl JL, Webber CA.

Res Microbiol. 1994 Jun-Aug;145(5-6):381-7. Review. No abstract available.

PMID:
7855423

Supplemental Content

Support Center